These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
13-D SC 13G 2/14/2018
13-D SC 13G/A 2/12/2018
13-D SC 13G 2/9/2018
8-K 8-K 2/8/2018 2/6/2018
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Entry into a Material Definitive Agreement and Financial Statements and Exhibits.
13-D SC 13G/A 2/7/2018
13-D SC 13G/A 1/19/2018
8-K 8-K 11/22/2017 11/20/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers and Financial Statements and Exhibits.
8-K 8-K 11/9/2017 11/9/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 11/9/2017 9/30/2017
8-K 8-K/A 10/12/2017 8/1/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Financial Statements and Exhibits.
13-D SC 13G 8/21/2017
8-K 8-K 8/3/2017 8/3/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 8/3/2017 8/1/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.
10-Q 10-Q 8/3/2017 6/30/2017
8-K 8-K 6/29/2017 6/27/2017
Abstract: On June 27, registrant announced the pricing of an underwritten public offering of 2,807,017 shares of its common stock at a public offering price of $42.75 per share. The underwriting agreement and the opinion and consent of Goodwin Procter LLP were included by exhibit.
Prospectus 424B5 6/29/2017
8-K 8-K/A 6/26/2017 6/22/2017
Abstract: Registrant filed an amendment to the Form 8-K filed June 23 to provide the historical financial statements of Spectrum Inc. under Item 9.01(a) and the pro forma financial information required under Item 9.01(b).
Prospectus 424B5 6/26/2017
8-K 8-K 6/23/2017 6/22/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Entry into a Material Definitive Agreement; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 5/23/2017 5/18/2017
Abstract: 8-K filed by Repligen Corp. (RGEN) covering Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holder; and Financial Statements and Exhibits.

Displaying 1 to 20 (of 120 filings)